[Questions on oncology].
Misset
J L
JL
Service de Cancérologie médicale, Hôpital Paul Brousse, Villejuif.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D000078224:Lenograstim; D009369:Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000078224:Lenograstim
Questions au cancérologue.